(Q41106518)

26 September 2017

1 reference

title

Serine/threonine kinase receptors and ligands (English)

1 reference

26 September 2017

Josso N

1

1 reference

26 September 2017

di Clemente N

series ordinal

2

1 reference

26 September 2017

publication date

1 June 1997

1 reference

Current Opinion in Genetics & Development

26 September 2017

published in

1 reference

26 September 2017

volume

7

1 reference

26 September 2017

issue

3

1 reference

26 September 2017

page(s)

371-377

1 reference

Mechanism of activation of the TGF-beta receptor

26 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2897%2980151-7

7 January 2021

Bone morphogenetic protein receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2897%2980151-7

7 January 2021

Complementation between kinase-defective and activation-defective TGF-beta receptors reveals a novel form of receptor cooperativity essential for signaling.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2897%2980151-7

7 January 2021

Signaling by chimeric erythropoietin-TGF-beta receptors: homodimerization of the cytoplasmic domain of the type I TGF-beta receptor and heterodimerization with the type II receptor are both required for intracellular signal transduction.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2897%2980151-7

7 January 2021

Signaling via hetero-oligomeric complexes of type I and type II serine/threonine kinase receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2897%2980151-7

7 January 2021

The GS domain of the transforming growth factor-beta type I receptor is important in signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2897%2980151-7

7 January 2021

Disruption of transforming growth factor beta signaling by a mutation that prevents transphosphorylation within the receptor complex.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2897%2980151-7

7 January 2021

Transforming growth factor-beta signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2897%2980151-7

7 January 2021

Activation of signalling by the activin receptor complex

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2897%2980151-7

7 January 2021

Truncated activin type II receptors inhibit bioactivity by the formation of heteromeric complexes with activin type I. receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2897%2980151-7

7 January 2021

Ligand-induced recruitment and phosphorylation of reduced TGF-beta type I receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2897%2980151-7

7 January 2021

Characterization of type I receptors for transforming growth factor-beta and activin

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2897%2980151-7

7 January 2021

Insensitivity to anti-müllerian hormone due to a mutation in the human anti-müllerian hormone receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2897%2980151-7

7 January 2021

Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2897%2980151-7

7 January 2021

Disruption of BMP signals in embryonic Xenopus ectoderm leads to direct neural induction

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2897%2980151-7

7 January 2021

Roads to neuralness: embryonic neural induction as derepression of a default state.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2897%2980151-7

7 January 2021

Vertebrate embryonic cells will become nerve cells unless told otherwise

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2897%2980151-7

7 January 2021

The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2897%2980151-7

7 January 2021

Dorsoventral patterning in Xenopus: inhibition of ventral signals by direct binding of chordin to BMP-4.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2897%2980151-7

7 January 2021

The Xenopus dorsalizing factor noggin ventralizes Drosophila embryos by preventing DPP from activating its receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2897%2980151-7

7 January 2021

Bmpr encodes a type I bone morphogenetic protein receptor that is essential for gastrulation during mouse embryogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2897%2980151-7

7 January 2021

Relationship between asymmetric nodal expression and the direction of embryonic turning

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2897%2980151-7

7 January 2021

Cloning and expression of the chick anti-Müllerian hormone gene.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2897%2980151-7

7 January 2021

Molecular cloning of an avian anti-Müllerian hormone homologue.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2897%2980151-7

7 January 2021

Bioactivation of Müllerian inhibiting substance during gonadal development by a kex2/subtilisin-like endoprotease

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2897%2980151-7

7 January 2021

Mutant Isoforms of the Anti-Müllerian Hormone Type II Receptor Are Not Expressed at the Cell Membrane

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2897%2980151-7

7 January 2021

A 27 base-pair deletion of the anti-müllerian type II receptor gene is the most common cause of the persistent müllerian duct syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2897%2980151-7

7 January 2021

Genetic analysis of the Müllerian-inhibiting substance signal transduction pathway in mammalian sexual differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2897%2980151-7

7 January 2021

Müllerian-inhibiting substance function during mammalian sexual development

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2897%2980151-7

7 January 2021

Activin signaling through activin receptor type II causes the cachexia-like symptoms in inhibin-deficient mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2897%2980151-7

7 January 2021

Synergistic effects of inhibins and müllerian-inhibiting substance on testicular tumorigenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2897%2980151-7

7 January 2021

Gonadotropins are essential modifier factors for gonadal tumor development in inhibin-deficient mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2897%2980151-7

7 January 2021

Growth differentiation factor-9 is required during early ovarian folliculogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2897%2980151-7

7 January 2021

Defects in enteric innervation and kidney development in mice lacking GDNF

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2897%2980151-7

7 January 2021

Renal agenesis and the absence of enteric neurons in mice lacking GDNF

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2897%2980151-7

7 January 2021

Renal and neuronal abnormalities in mice lacking GDNF

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2897%2980151-7

7 January 2021

Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2897%2980151-7

7 January 2021

De novo mutation of GDNF, ligand for the RET/GDNFR-alpha receptor complex, in Hirschsprung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2897%2980151-7

7 January 2021

Functional receptor for GDNF encoded by the c-ret proto-oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2897%2980151-7

7 January 2021

GDNF signalling through the Ret receptor tyrosine kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2897%2980151-7

7 January 2021

GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2897%2980151-7

7 January 2021

Characterization of a multicomponent receptor for GDNF.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2897%2980151-7

7 January 2021

A WD-domain protein that is associated with and phosphorylated by the type II TGF-beta receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2897%2980151-7

7 January 2021

The p21(RAS) farnesyltransferase alpha subunit in TGF-beta and activin signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2897%2980151-7

7 January 2021

The immunophilin FKBP12 functions as a common inhibitor of the TGF beta family type I receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2897%2980151-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2897%2980151-7

7 January 2021

Caenorhabditis elegans genes sma-2, sma-3, and sma-4 define a conserved family of transforming growth factor beta pathway components

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2897%2980151-7

7 January 2021

Xenopus Mad proteins transduce distinct subsets of signals for the TGF beta superfamily.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2897%2980151-7

7 January 2021

A novel mesoderm inducer, Madr2, functions in the activin signal transduction pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2897%2980151-7

7 January 2021

A human Mad protein acting as a BMP-regulated transcriptional activator

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2897%2980151-7

7 January 2021

Receptor-associated Mad homologues synergize as effectors of the TGF-beta response

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2897%2980151-7

7 January 2021

MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2897%2980151-7

7 January 2021

Mad-related genes in the human

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2897%2980151-7

7 January 2021

DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2897%2980151-7

7 January 2021

TGFbeta signaling: receptors, transducers, and Mad proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2897%2980151-7

7 January 2021

MADR2 is a substrate of the TGFbeta receptor and its phosphorylation is required for nuclear accumulation and signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2897%2980151-7

7 January 2021

Serine phosphorylation, chromosomal localization, and transforming growth factor-beta signal transduction by human bsp-1

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2897%2980151-7

7 January 2021

Signaling activity of transforming growth factor beta type II receptors lacking specific domains in the cytoplasmic region

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2897%2980151-7

7 January 2021

Inactive type II and type I receptors for TGF beta are dominant inhibitors of TGF beta-dependent transcription

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2897%2980151-7

7 January 2021

TGF beta signals through a heteromeric protein kinase receptor complex

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2897%2980151-7

7 January 2021

10.1016/S0959-437X(97)80151-7

Identifiers

DOI

1 reference

26 September 2017

1 reference